Skip to main content
See every side of every news story
Published loading...Updated

Trump administration announces drug pricing deals with Teva, Astellas and others

The companies will offer lower prices tied to other wealthy countries and give state Medicaid programs discounts, the White House said.

  • President Donald Trump announced new drug pricing deals with nearly a dozen pharmaceutical companies, including Teva and Astellas, to lower medication costs by matching prices paid abroad for state Medicaid programs.
  • The Trump administration has secured deals with multiple drugmakers aiming to reduce prices on a large portion of brand-name drugs, while participation by states in Medicaid remains optional and details have not been fully disclosed.
  • Consumer advocacy group Public Citizen criticized the deals as lacking evidence of effectiveness and transparent terms, questioning their benefit to consumers.
  • Pharmaceutical companies have responded to pricing pressures by increasing domestic manufacturing and expanding direct-to-consumer sales, while U.S. drug prices remain significantly higher than overseas rates.
Insights by Ground AI

38 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 56% of the sources are Center
56% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The National Desk broke the news in Washington, United States on Monday, August 31, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal